BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38486989)

  • 1. A "One-Step" Strategy for the Global Characterization of Core-Fucosylated Glycoproteome.
    Wang Y; Yuan R; Liang B; Zhang J; Wen Q; Chen H; Tian Y; Wen L; Zhou H
    JACS Au; 2024 May; 4(5):2005-2018. PubMed ID: 38818065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Recent advances in discovering molecular targets for cancer therapy.
    Yang Z; Wang T
    Front Med (Lausanne); 2024; 11():1403466. PubMed ID: 38779619
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of
    Lin Y; Lubman DM
    Acta Pharm Sin B; 2024 Mar; 14(3):1098-1110. PubMed ID: 38486989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Large-scale enrichment and identification of human urinary
    Shang S; Dong H; Li Y; Zhang W; Li H; Qin W; Qian X
    Se Pu; 2021 Jul; 39(7):686-694. PubMed ID: 34227365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
    Guo Y; Jia W; Yang J; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
    Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
    Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
    Liu L; Qin H; Ye M
    Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD).
    Chen Z; Yu Q; Hao L; Liu F; Johnson J; Tian Z; Kao WJ; Xu W; Li L
    Analyst; 2018 May; 143(11):2508-2519. PubMed ID: 29687791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS.
    Tan Y; Zhu J; Gutierrez Reyes CD; Lin Y; Tan Z; Wu Z; Zhang J; Cano A; Verschleisser S; Mechref Y; Singal AG; Parikh ND; Lubman DM
    ACS Omega; 2023 Apr; 8(13):12467-12480. PubMed ID: 37033807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach.
    Mechref Y; Peng W; Gautam S; Ahmadi P; Lin Y; Zhu J; Zhang J; Liu S; Singal AG; Parikh ND; Lubman DM
    Adv Cancer Res; 2023; 157():23-56. PubMed ID: 36725111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.
    Lin Y; Zhu J; Zhang J; Dai J; Liu S; Arroyo A; Rose M; Singal AG; Parikh ND; Lubman DM
    ACS Omega; 2022 Jul; 7(26):22850-22860. PubMed ID: 35811936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
    Lin Y; Zhang J; Arroyo A; Singal AG; Parikh ND; Lubman DM
    Front Oncol; 2022; 12():818001. PubMed ID: 35372033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology, function, and applications of exosomes in cancer.
    Liu J; Ren L; Li S; Li W; Zheng X; Yang Y; Fu W; Yi J; Wang J; Du G
    Acta Pharm Sin B; 2021 Sep; 11(9):2783-2797. PubMed ID: 34589397
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.